59 related articles for article (PubMed ID: 38470543)
1. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression.
Cui Y; Lv P; Zhang C
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23749. PubMed ID: 38800929
[TBL] [Abstract][Full Text] [Related]
2. Decrease in GPSM2 mediated by the natural product luteolin contributes to colon adenocarcinoma treatment and increases the sensitivity to fluorouracil.
Yang C; Wu L; Jin X; Liu A; Jing Z; Feng C; Guo Z; Zhang Y; Ma Y; Li F; Wen Z; Yan L; Yang Y; Ji X; Zhang Y
Biomed Pharmacother; 2024 May; 176():116847. PubMed ID: 38823277
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase BRCC3 promotes the migration, invasion and EMT progression of colon adenocarcinoma by stabilizing MET expression.
Feng X; He S; Chen Y; Zhang L
Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells.
Huang Q; Zheng S; Gu H; Yang Z; Lu Y; Yu X; Guo G
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):564-575. PubMed ID: 38449391
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.
Zhang F; Zhou Q
Mol Med Rep; 2018 Dec; 18(6):4886-4894. PubMed ID: 30272359
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway.
Zhao Z; Qin X
Sci Rep; 2020 Oct; 10(1):16729. PubMed ID: 33028966
[TBL] [Abstract][Full Text] [Related]
7. The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4.
Zhang W; Hu Y; Zhang W; Yi K; Xu X; Chen Z
J Immunol Res; 2022; 2022():9385820. PubMed ID: 35692499
[TBL] [Abstract][Full Text] [Related]
8. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis.
Miao Z; Liu S; Xiao X; Li D
Gene; 2020 Jun; 743():144604. PubMed ID: 32213297
[TBL] [Abstract][Full Text] [Related]
9. Cancer treatment and survivorship statistics, 2022.
Miller KD; Nogueira L; Devasia T; Mariotto AB; Yabroff KR; Jemal A; Kramer J; Siegel RL
CA Cancer J Clin; 2022 Sep; 72(5):409-436. PubMed ID: 35736631
[TBL] [Abstract][Full Text] [Related]
10. Clinical Updates for Colon Cancer Care in 2022.
Fabregas JC; Ramnaraign B; George TJ
Clin Colorectal Cancer; 2022 Sep; 21(3):198-203. PubMed ID: 35729033
[TBL] [Abstract][Full Text] [Related]
11. ORP5 promotes tumor metastasis via stabilizing c-Met in renal cell carcinoma.
Song L; Zhang L; Zhou Y; Shao X; Xu Y; Pei D; Wang Q
Cell Death Discov; 2022 Apr; 8(1):219. PubMed ID: 35449154
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer.
Raj S; Kesari KK; Kumar A; Rathi B; Sharma A; Gupta PK; Jha SK; Jha NK; Slama P; Roychoudhury S; Kumar D
Mol Cancer; 2022 Jan; 21(1):31. PubMed ID: 35081970
[TBL] [Abstract][Full Text] [Related]
13. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer.
Vogel JD; Felder SI; Bhama AR; Hawkins AT; Langenfeld SJ; Shaffer VO; Thorsen AJ; Weiser MR; Chang GJ; Lightner AL; Feingold DL; Paquette IM
Dis Colon Rectum; 2022 Feb; 65(2):148-177. PubMed ID: 34775402
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
